BLT 0.00% 2.6¢ benitec biopharma limited

Interesting article on GT and pharma, page-9

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Here is a curve ball. Peter was absent at the AGM because he wanted to be present when David Suhy announced the SVR for TT-034, cohort 3 at the Liver meeting. Now that would be worth an apology from me but I doubt that I will have to make that apology. The best we can hope for is a comparison of the trial data and the replicon results. If that was announced, then I would be happy.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.